Zoetis Inc
Suletud
SektorTervishoid
78.07 1.63
Ülevaade
Aktsiahinna muutus
24h
Min
76.41
Max
79.02
Sissetulek | -2M 601M |
|---|---|
Müük | -125M 2.3B |
P/E Sektori keskmine | 12.441 50.958 |
Aktsiakasum | 1.42 |
Dividenditootlus | 2.58 |
Kasumimarginaal | 26.569 |
Töötajad | 14,500 |
EBITDA | -8M 939M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +52.29% upside |
Dividenditootlus Sektori keskmine | 2.58% 2.41% |
|---|---|
Järgmine tulemuste avaldamine | 4. aug 2026 |
Järgmine dividendimakse kuupäev | 1. sept 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 20. juuli 2026 |
Turukapital | -16B 32B |
|---|---|
Eelmine avamishind | 76.44 |
Eelmine sulgemishind | 78.07 |
Uudiste sentiment
By Acuity
56%
44%
275 / 342 Pingereas Healthcare
Zoetis Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Zoetis Inc
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.